Log in to save to my catalogue

Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes

Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_505e44be1dd441bfb7ad630258f5cddb

Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes

About this item

Full title

Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes

Publisher

London: Springer Nature

Journal title

NPJ Parkinson's Disease, 2022-04, Vol.8 (1), p.51-51, Article 51

Language

English

Formats

Publication information

Publisher

London: Springer Nature

More information

Scope and Contents

Contents

© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Alpha-synuclein (aSyn) is a central player in the pathogenesis of synucleinopathies due to its accumulation in typical protein aggregates in the brain. However, it is still unclear how it contributes to neurodegeneration. Type-2 diabetes mellitus is a risk factor for Parkinson's disease (PD). Interestingly, a common molecular alteration am...

Alternative Titles

Full title

Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_505e44be1dd441bfb7ad630258f5cddb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_505e44be1dd441bfb7ad630258f5cddb

Other Identifiers

ISSN

2373-8057

E-ISSN

2373-8057

DOI

10.1038/s41531-022-00314-x

How to access this item